BERETA®

RABEPRAZOLE
BERETA®

Available Presentations:

  • ENTERIC-COATED TABLETS, 10 mg, No. 14; 20 mg, No. 14
Product for treatment of gastric and duodenal ulcers, gastroesophageal reflux disease (GERD), reflux esophagitis. Long-term reduction of gastric acidity.
INN: rabeprazole
Pharmacotherapeutic Group: down-regulator of gastric secretion, proton pump inhibitor.
Presentation: enteric-coated tablets
10 mg, No. 14; 20 mg, No. 14
Authorization Number: LP – 001953 of 25 December 2012
ATC Code: А02ВС04
Dispensing Rules: on prescription.
For complete information, see the Label.

THE INFORMATION ON THIS PAGE IS NOT AN ADVERTISEMENT AND IS INTENDED TO INFORM ON THE PRODUCTS MANUFACTURED BY THE COMPANY.

THE MEDICINAL PRODUCTS HAVE CONTRAINDICATIONS, CONTACT YOUR DOCTOR.